Information2024
- Nov. 01, 2024 IRNotice Regarding Status of Share Repurchase
- Oct. 28, 2024 IRNotice Regarding Change in Representative Executive Officer
- Oct. 21, 2024 Corporate【Notice】New "True to Life Story" featuring the experience of an Olympus employee with irritable bowel syndrome and colon polyps is now live
- Oct. 16, 2024 IRNotice Concerning Ruling of the Lawsuit involving Consolidated Subsidiary
- Oct. 01, 2024 IRNotice Regarding Status of Share Repurchase
- Sep. 02, 2024 IRNotice Regarding Status of Share Repurchase
- Aug. 20, 2024 CorporateAnnual update of Sustainability Page
- Aug. 07, 2024 IRFirst Quarter Financial Results
- Aug. 07, 2024 IRNotice Concerning Change of Executive Officers
- Aug. 07, 2024 IR(Progress of disclosure matters) Notice Concerning Transfer of Orthopedic Business
- Aug. 01, 2024 IRNotice Regarding Status of Share Repurchase
- Jul. 24, 2024 IRNotice of Completion of Payment for Disposal of Treasury Shares based on Subsequent Grant-type Restricted Stock Compensation and Performance-linked Stock Compensation Systems
- Jul. 19, 2024 Corporate【Notice】 New "True to Life Story" featuring the endoscopy experience of Japanese actor Takeshi Tsuruno is now live
- Jul. 12, 2024 IR(Progress of disclosure matters) Notice Concerning Transfer of Orthopedic Business
- Jul. 01, 2024 IRNotice Regarding Status of Share Repurchase
- Jun. 26, 2024 IRNotice of Disposal of Treasury Shares based on Subsequent Grant-type Restricted Stock Compensation and Performance-linked Stock Compensation Systems
- Jun. 18, 2024 IROverview of Evaluation Results on the Effectiveness of the Board of Directors of Olympus
- Jun. 10, 2024 IRNotice of Completion of Payment for Disposal of Treasury Shares based on Subsequent Grant-type Restricted Stock Compensation and Performance-linked Stock Compensation Systems and Partial Loss of Rights
- Jun. 04, 2024 IRNotice Regarding Status of Share Repurchase
- May. 27, 2024 IRNotice Concerning Transfer of Orthopedic Business
- May. 13, 2024 IRNotice of Disposal of Treasury Shares based on Subsequent Grant-type Restricted Stock Unit Compensation and Performance-linked Stock Compensation Systems
- May. 10, 2024 IRNotice Regarding Share Repurchase and Cancellation of Treasury Shares
- May. 10, 2024 IRFinancial Results
- May. 01, 2024 Corporate[Notice] Launch of new True to Life story that introduces a new initiative using digital technologies to address challenges in local gastric cancer screenings
- Apr. 25, 2024 Corporate[Notice] New True to Life story featured “C-TEC” the Endoscopy Training Center is now launched
- Apr. 08, 2024 IRNotice Concerning the start of the process to return certain land and building in Shenzhen
- Mar. 28, 2024 IR(Progress of disclosure matters) Notice Concerning the Impact of the 2024 Noto Peninsula Earthquake
- Mar. 28, 2024 IRNotification for the Candidates for the Board of Directors
- Mar. 26, 2024 IRNotice Regarding Completion of Share Repurchase and Cancellation of Treasury Shares
- Mar. 08, 2024 IRNotice Regarding Rescission of Definitive Agreement to Acquire shares of Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd.
- Mar. 04, 2024 IRNotice Regarding Status of Share Repurchase
- Mar. 01, 2024 IR(Progress of disclosure matters) Notice Concerning the Impact of the 2024 Noto Peninsula Earthquake
- Feb. 14, 2024 IRThird Quarter Financial Results
- Feb. 14, 2024 IRNotice Concerning the Revision of Financial Forecast
- Feb. 09, 2024 IRNotice Concerning the Impact of the 2024 Noto Peninsula Earthquake
- Feb. 02, 2024 IRNotice Regarding Status of Share Repurchase
- Jan. 31, 2024 IRNotice Concerning Change of Executive Officers
- Jan. 25, 2024 IR(Updated) (Progress of disclosure matters) Notice Regarding Completion of Acquisition of Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd. (to make it a subsidiary)
- Jan. 24, 2024 IR(Progress of disclosure matters) Notice Regarding Completion of Acquisition of Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd. (to make it a subsidiary)
- Jan. 05, 2024 IRNotice Regarding Status of Share Repurchase